Global /India /Healthcare /Drug Manufacturers - General /AARTIPHARM
chevron_leftBack
Aarti Pharmalabs Ltd. logo

Aarti Pharmalabs Ltd.

AARTIPHARM
NSE: AARTIPHARM Delayed
740.25INR 4.4%
7.73 USD
As of 5 June 2026, Aarti Pharmalabs Ltd. has a market cap of $671.38M USD, ranking #13195 globally and #717 in India. It ranks #1198 in the Healthcare sector, and #443 in the Drug Manufacturers - General industry.
Global Rank
13195
Country Rank
717
Sector Rank
1198
Industry Rank
443
Key Stats
Market Cap
$671.38MUSD
64.29B INR
Enterprise Value
$736.04MUSD
70.48B INR
Revenue (TTM)
$188.05MUSD
18.01B INR
EBITDA (TTM)
$41.97MUSD
4.02B INR
Net Income (TTM)
$22.32MUSD
2.14B INR
EBITDA Margin
22%
Profit Margin
12%
PE Ratio
30.1
PS Ratio
3.6
PB Ratio
3.1
EV/EBITDA
17.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
2,162
Founded
2019
Website
aartipharmalabs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
4.4% 0.3% 16% -7% -16% -2.7%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
AARTIPHARM
Aarti Pharmalabs Ltd
ISIN: INE0LRU01027
Shares Out.:
90.658M1 Shares Float: 50.366M2
TV:
SA:
YF:
GF:
BA:
MS:
740.25 INR
Bombay Stock Exchange
MIC: XBOM
543748 (AARTIPHARM)
Aarti Pharmalabs Ltd
ISIN: INE0LRU01027
TV:
SA:
YF:
GF:
BA:
MS:
709.45 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Aarti Pharmalabs Ltd.

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.57B
4.27T INR
7K%
39.1
DIVISLAB
$18.12B
1.73T INR
3K%
70.0
$14.95B
1.43T INR
2K%
63.0
$11.57B
1.11T INR
2K%
19.6
MANKIND
$9.73B
931.67B INR
1K%
52.2
ZYDUSLIFE
$9.57B
916.53B INR
1K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
113K%
38.1
JNJ
$547.28B
81K%
26.4
ABBV
$360.63B
54K%
97.4
$324.68B
256.25B CHF
48K%
19.9
AZN
$289.43B
215.59B GBP
43K%
27.6
NOVN
$277.35B
218.9B CHF
41K%
20.5
chevron_leftBack